BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,529 | +43.5% | 279,000 | +73.3% | 0.05% | +51.6% |
| Q2 2023 | $7,335 | -40.6% | 161,000 | -47.1% | 0.03% | +63.2% |
| Q1 2023 | $12,342 | +59.6% | 304,326 | +100.5% | 0.02% | -45.7% |
| Q4 2022 | $7,735 | -99.9% | 151,756 | -18.0% | 0.04% | -27.1% |
| Q3 2022 | $9,969,000 | -17.4% | 185,095 | -1.5% | 0.05% | -11.1% |
| Q2 2022 | $12,066,000 | -16.4% | 187,869 | +0.9% | 0.05% | +1.9% |
| Q1 2022 | $14,434,000 | +5.5% | 186,161 | +16.8% | 0.05% | +10.4% |
| Q4 2021 | $13,686,000 | +4.8% | 159,440 | -1.8% | 0.05% | -2.0% |
| Q3 2021 | $13,059,000 | -8.8% | 162,367 | -8.7% | 0.05% | -3.9% |
| Q2 2021 | $14,313,000 | -11.4% | 177,803 | -7.2% | 0.05% | -16.4% |
| Q1 2021 | $16,156,000 | -10.1% | 191,567 | -14.4% | 0.06% | -11.6% |
| Q4 2020 | $17,967,000 | -5.5% | 223,921 | -5.3% | 0.07% | -13.8% |
| Q3 2020 | $19,008,000 | -9.9% | 236,366 | -3.6% | 0.08% | -13.0% |
| Q2 2020 | $21,100,000 | +11.2% | 245,071 | +4.9% | 0.09% | -8.0% |
| Q1 2020 | $18,972,000 | -5.5% | 233,685 | -2.7% | 0.10% | +19.0% |
| Q4 2019 | $20,078,000 | -54.5% | 240,114 | -52.4% | 0.08% | -13.4% |
| Q3 2019 | $44,092,000 | +110.8% | 504,084 | +97.4% | 0.10% | +4.3% |
| Q2 2019 | $20,918,000 | -7.7% | 255,411 | -8.4% | 0.09% | -9.7% |
| Q1 2019 | $22,668,000 | +23.6% | 278,796 | +0.1% | 0.10% | +10.8% |
| Q4 2018 | $18,336,000 | -10.3% | 278,589 | +5.1% | 0.09% | +3.3% |
| Q3 2018 | $20,434,000 | -4.0% | 265,074 | -8.0% | 0.09% | -2.2% |
| Q2 2018 | $21,285,000 | +8.6% | 288,271 | -4.3% | 0.09% | +5.7% |
| Q1 2018 | $19,593,000 | -0.2% | 301,254 | -0.8% | 0.09% | +3.6% |
| Q4 2017 | $19,625,000 | +0.7% | 303,607 | -2.3% | 0.08% | 0.0% |
| Q3 2017 | $19,494,000 | +4.2% | 310,669 | +0.5% | 0.08% | +1.2% |
| Q2 2017 | $18,715,000 | +12.6% | 309,143 | -3.6% | 0.08% | +15.3% |
| Q1 2017 | $16,628,000 | +15.8% | 320,646 | -1.0% | 0.07% | +14.3% |
| Q4 2016 | $14,360,000 | -7.3% | 323,880 | -0.4% | 0.06% | -8.7% |
| Q3 2016 | $15,484,000 | +2.8% | 325,307 | -2.4% | 0.07% | +3.0% |
| Q2 2016 | $15,064,000 | +7.3% | 333,146 | -2.5% | 0.07% | +13.6% |
| Q1 2016 | $14,042,000 | +7.9% | 341,839 | +0.2% | 0.06% | +1.7% |
| Q4 2015 | $13,013,000 | +16.0% | 341,125 | -0.1% | 0.06% | +9.4% |
| Q3 2015 | $11,222,000 | -13.0% | 341,633 | +3.1% | 0.05% | -7.0% |
| Q2 2015 | $12,897,000 | -42.6% | 331,209 | +1.0% | 0.06% | -42.4% |
| Q1 2015 | $22,460,000 | -8.8% | 327,888 | -2.4% | 0.10% | -7.5% |
| Q4 2014 | $24,615,000 | -2.1% | 335,851 | -4.1% | 0.11% | +78.3% |
| Q3 2014 | $25,144,000 | -0.7% | 350,346 | 0.0% | 0.06% | -46.9% |
| Q2 2014 | $25,330,000 | -6.6% | 350,346 | -4.9% | 0.11% | -7.4% |
| Q1 2014 | $27,112,000 | +3.7% | 368,475 | -1.9% | 0.12% | +3.4% |
| Q4 2013 | $26,135,000 | -35.7% | 375,775 | -39.2% | 0.12% | -34.1% |
| Q3 2013 | $40,621,000 | -3.2% | 618,375 | +2.0% | 0.18% | -0.6% |
| Q2 2013 | $41,981,000 | – | 606,042 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |